Research: MCCULLOCH and colleagues,

Listed in Issue 85

Abstract

MCCULLOCH and colleagues, Pine Street Clinic, San Anselmo, CA, USA, analyze Chinese herbal medicine and interferon in the treatment of chronic hepatitis B.

Background

This meta-analysis was performed in order to evaluate the effectiveness of Chinese herbal medicine alone or in combination with interferon-alpha in treating chronic hepatitis B .

Methodology

TCMLARS, AMED, CISCOM, EMBASE, MEDLINE,and Cochrane Collaboration databases were searched and the articles' bibliographies were handsearched .

Results

Chinese herbal medicine significantly reduced sero-reversion of HbsAg and was equivalent to interferon-alpha in sero-reversion of HbeAg and Hepatitis B virus DNA . Chinese herbal medicine combined with interferon-alpha significantly increased seor-reversion of HBsAg, HBeAg, and viral DNA . The Chinese herb active component bufotoxin combined with Interferon-alpha significantly increased HbeAg and viral DNA sero-reversion . The Chinese herb active component kurorinone was equivalent to interferon-alpha in sero-reversion of HbeAg and viral DNA .

Conclusion

Although the quality of existing studies is poor, the data nevertheless suggest that further studies of Chinese herbal medicine and interferon in chronic hepatitis B infection are justified .

References

McCulloch M, Broffman M, Gao J, Colford JMJr. Chinese herbal medicine and interferon in the treatment of chronic hepatitis B: a meta-analysis of randomized. controlled trials. American Journal of Public Health 91 (10): 1619-1628, Oct 2002.

ICAN 2024 Skyscraper

Scientific and Medical Network 2

Cycle Around the World for Charity 2023

Climb Mount Kilimanjaro Charity 2023

top of the page